Synergistic Effect of HMGB1 Knockdown and Cordycepin in the K562 Human Chronic Myeloid Leukemia Cell Line

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2015.3928
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Reversal Effect of Arsenic Sensitivity in Human Leukemia Cell Line K562 and K562/Adm Using Realgar Transforming Solution

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2013English

Single-Nucleotide Polymorphisms of ABCG2 Increase the Efficacy of Tyrosine Kinase Inhibitors in the K562 Chronic Myeloid Leukemia Cell Line

Pharmacogenetics and Genomics
Molecular MedicineGeneticsMolecular Biology
2014English

Cytotoxic Effects of Some Flavonoids and Imatinib on the K562 Chronic Myeloid Leukemia Cell Line: Data Analysis Using the Combination Index Method

Balkan Medical Journal
Medicine
2019English

ITR‑284 Modulates Cell Differentiation in Human Chronic Myelogenous Leukemia K562 Cells

Oncology Reports
MedicineCancer ResearchOncology
2017English

Effects of Epigallocatechin-3-Gallate (EGCG) on Cell Cycle Distribution and DNA Integrity of K562 Cells, a Human Chronic Myeloid Leukemia

Jurnal Sains Kesihatan Malaysia
2020English

Global Proteome Quantification for Discovering Imatinib-Induced Perturbation of Multiple Biological Pathways in K562 Human Chronic Myeloid Leukemia Cells

Journal of Proteome Research
BiochemistryChemistry
2010English

A Stronger Reversal Effect of the Combination of Dasatinib and Menadione on P-Gp-Mediated Multidrug Resistance in Human Leukemia K562/Adr Cell Line

RSC Advances
ChemistryChemical Engineering
2017English

TRIB2 Knockdown as a Regulator of Chemotherapy Resistance and Proliferation via the ERK/STAT3 Signaling Pathway in Human Chronic Myelogenous Leukemia K562/Adm Cells

Oncology Reports
MedicineCancer ResearchOncology
2018English

Long-Term Outcomes in the Second-Line Treatment of Chronic Myeloid Leukemia

Cancer
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy